Selected research
Industry Research
Lesinurad Industry Research Report 2026
Market perspective
The global Lesinurad market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lesinurad is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lesinurad is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lesinurad is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lesinurad include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lesinurad market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Lesinurad.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lesinurad Market by Company
Ausun Pharmaceutical
Cayman Chemical
CHEMO
Clearsynth
Manus Aktteva Biopharma LLP
MSN Labs
Nifty Labs
Target Mol
UQUIFA
Meso Chem
Vcare Pharmatech
Lesinurad Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Lesinurad Segment by Application
Research Institute
Pharmaceutical
Others
Lesinurad Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lesinurad market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lesinurad and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lesinurad.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lesinurad manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lesinurad by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lesinurad in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98 %
- Purity ≥ 99 %
Applications
- Research Institute
- Pharmaceutical
- Others
Companies covered
- Ausun Pharmaceutical
- Cayman Chemical
- CHEMO
- Clearsynth
- Manus Aktteva Biopharma LLP
- MSN Labs
- Nifty Labs
- Target Mol
- UQUIFA
- Meso Chem
- Vcare Pharmatech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Lesinurad by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity ≥ 98 %
- 2.2.3 Purity ≥ 99 %
- 2.3 Lesinurad by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Research Institute
- 2.3.3 Pharmaceutical
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Lesinurad Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Lesinurad Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Lesinurad Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Lesinurad Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lesinurad Production by Manufacturers (2021-2026)
- 3.2 Global Lesinurad Production Value by Manufacturers (2021-2026)
- 3.3 Global Lesinurad Average Price by Manufacturers (2021-2026)
- 3.4 Global Lesinurad Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lesinurad Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Lesinurad Manufacturers, Product Type & Application
- 3.7 Global Lesinurad Manufacturers Established Date
- 3.8 Global Lesinurad Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ausun Pharmaceutical
- 4.1.1 Ausun Pharmaceutical Lesinurad Company Information
- 4.1.2 Ausun Pharmaceutical Lesinurad Business Overview
- 4.1.3 Ausun Pharmaceutical Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ausun Pharmaceutical Product Portfolio
- 4.1.5 Ausun Pharmaceutical Recent Developments
- 4.2 Cayman Chemical
- 4.2.1 Cayman Chemical Lesinurad Company Information
- 4.2.2 Cayman Chemical Lesinurad Business Overview
- 4.2.3 Cayman Chemical Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Cayman Chemical Product Portfolio
- 4.2.5 Cayman Chemical Recent Developments
- 4.3 CHEMO
- 4.3.1 CHEMO Lesinurad Company Information
- 4.3.2 CHEMO Lesinurad Business Overview
- 4.3.3 CHEMO Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 CHEMO Product Portfolio
- 4.3.5 CHEMO Recent Developments
- 4.4 Clearsynth
- 4.4.1 Clearsynth Lesinurad Company Information
- 4.4.2 Clearsynth Lesinurad Business Overview
- 4.4.3 Clearsynth Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Clearsynth Product Portfolio
- 4.4.5 Clearsynth Recent Developments
- 4.5 Manus Aktteva Biopharma LLP
- 4.5.1 Manus Aktteva Biopharma LLP Lesinurad Company Information
- 4.5.2 Manus Aktteva Biopharma LLP Lesinurad Business Overview
- 4.5.3 Manus Aktteva Biopharma LLP Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Manus Aktteva Biopharma LLP Product Portfolio
- 4.5.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.6 MSN Labs
- 4.6.1 MSN Labs Lesinurad Company Information
- 4.6.2 MSN Labs Lesinurad Business Overview
- 4.6.3 MSN Labs Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 MSN Labs Product Portfolio
- 4.6.5 MSN Labs Recent Developments
- 4.7 Nifty Labs
- 4.7.1 Nifty Labs Lesinurad Company Information
- 4.7.2 Nifty Labs Lesinurad Business Overview
- 4.7.3 Nifty Labs Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Nifty Labs Product Portfolio
- 4.7.5 Nifty Labs Recent Developments
- 4.8 Target Mol
- 4.8.1 Target Mol Lesinurad Company Information
- 4.8.2 Target Mol Lesinurad Business Overview
- 4.8.3 Target Mol Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Target Mol Product Portfolio
- 4.8.5 Target Mol Recent Developments
- 4.9 UQUIFA
- 4.9.1 UQUIFA Lesinurad Company Information
- 4.9.2 UQUIFA Lesinurad Business Overview
- 4.9.3 UQUIFA Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 UQUIFA Product Portfolio
- 4.9.5 UQUIFA Recent Developments
- 4.10 Meso Chem
- 4.10.1 Meso Chem Lesinurad Company Information
- 4.10.2 Meso Chem Lesinurad Business Overview
- 4.10.3 Meso Chem Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Meso Chem Product Portfolio
- 4.10.5 Meso Chem Recent Developments
- 4.11 Vcare Pharmatech
- 4.11.1 Vcare Pharmatech Lesinurad Company Information
- 4.11.2 Vcare Pharmatech Lesinurad Business Overview
- 4.11.3 Vcare Pharmatech Lesinurad Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Vcare Pharmatech Product Portfolio
- 4.11.5 Vcare Pharmatech Recent Developments
5 Global Lesinurad Production by Region
- 5.1 Global Lesinurad Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lesinurad Production by Region: 2021-2032
- 5.2.1 Global Lesinurad Production by Region: 2021-2026
- 5.2.2 Global Lesinurad Production Forecast by Region (2027-2032)
- 5.3 Global Lesinurad Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Lesinurad Production Value by Region: 2021-2032
- 5.4.1 Global Lesinurad Production Value by Region: 2021-2026
- 5.4.2 Global Lesinurad Production Value Forecast by Region (2027-2032)
- 5.5 Global Lesinurad Market Price Analysis by Region (2021-2026)
- 5.6 Global Lesinurad Production and Value, YOY Growth
- 5.6.1 North America Lesinurad Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Lesinurad Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Lesinurad Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Lesinurad Production Value Estimates and Forecasts (2021-2032)
6 Global Lesinurad Consumption by Region
- 6.1 Global Lesinurad Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lesinurad Consumption by Region (2021-2032)
- 6.2.1 Global Lesinurad Consumption by Region: 2021-2026
- 6.2.2 Global Lesinurad Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lesinurad Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lesinurad Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lesinurad Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Lesinurad Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Lesinurad Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Lesinurad Production by Type (2021-2032)
- 7.1.1 Global Lesinurad Production by Type (2021-2032) & (t)
- 7.1.2 Global Lesinurad Production Market Share by Type (2021-2032)
- 7.2 Global Lesinurad Production Value by Type (2021-2032)
- 7.2.1 Global Lesinurad Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Lesinurad Production Value Market Share by Type (2021-2032)
- 7.3 Global Lesinurad Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Lesinurad Production by Application (2021-2032)
- 8.1.1 Global Lesinurad Production by Application (2021-2032) & (t)
- 8.1.2 Global Lesinurad Production Market Share by Application (2021-2032)
- 8.2 Global Lesinurad Production Value by Application (2021-2032)
- 8.2.1 Global Lesinurad Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Lesinurad Production Value Market Share by Application (2021-2032)
- 8.3 Global Lesinurad Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Lesinurad Value Chain Analysis
- 9.1.1 Lesinurad Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Lesinurad Production Mode & Process
- 9.2 Lesinurad Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lesinurad Distributors
- 9.2.3 Lesinurad Customers
10 Global Lesinurad Analyzing Market Dynamics
- 10.1 Lesinurad Industry Trends
- 10.2 Lesinurad Industry Drivers
- 10.3 Lesinurad Industry Opportunities and Challenges
- 10.4 Lesinurad Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst